Free tool
FAERS Monitor: Dobutamine Hydrochloride In Dextrose 5% In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020255 or its brand name (Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Dobutamine Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
1,297
Serious
1,252
97% of reports
Hospitalization
450
Death reported
543
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- death271
- stress179
- off label use162
- sepsis155
- multiple organ dysfunction syndrome148
- condition aggravated145
- general physical health deterioration140
- drug ineffective133
- hyponatraemia132
- cardiogenic shock129
- nausea124
- ascites120
- pain120
- ventricular fibrillation119
- vomiting117
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 8 |
| 2005 | 1 |
| 2007 | 11 |
| 2008 | 18 |
| 2009 | 14 |
| 2010 | 29 |
| 2011 | 106 |
| 2012 | 22 |
| 2013 | 35 |
| 2014 | 48 |
| 2015 | 196 |
| 2016 | 29 |
| 2017 | 85 |
| 2018 | 95 |
| 2019 | 24 |
| 2020 | 27 |
| 2021 | 88 |
| 2022 | 94 |
| 2023 | 151 |
| 2024 | 75 |
| 2025 | 77 |
| 2026 | 64 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,862 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| ventricular fibrillationSignal | 119 | 175.6 | 147.8 | 20,275 |
| cardiogenic shockSignal | 129 | 147.1 | 124.8 | 18,417 |
| multiple organ dysfunction syndromeSignal | 148 | 85.2 | 73.2 | 12,179 |
| ascitesSignal | 120 | 66.5 | 56.0 | 7,651 |
| stressSignal | 179 | 40.4 | 35.2 | 6,838 |
| hyponatraemiaSignal | 132 | 38.1 | 32.4 | 4,733 |
| sepsisSignal | 155 | 22.6 | 19.5 | 3,185 |
| general physical health deteriorationSignal | 140 | 19.6 | 16.8 | 2,469 |
| condition aggravatedSignal | 145 | 7.7 | 6.6 | 856 |
| deathSignal | 271 | 5.1 | 4.6 | 927 |
| vomitingSignal | 117 | 4.0 | 3.4 | 270 |
| painSignal | 120 | 3.2 | 2.7 | 181 |
| off label useSignal | 162 | 3.0 | 2.6 | 223 |
| nauseaSignal | 124 | 2.5 | 2.1 | 119 |
| drug ineffective | 133 | 1.6 | 1.4 | 34 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.